Company: TACOW
Filing Date: 2025-04-15
Form Type: S-1/A
Source: 0001829126-25-002650
Chunk: 116

Company: Berto Acquisition Corp.
Filing Date: 2025-04-15
Form: S-1/A
Chunk 116
---
Further, if we were no longer listed on Nasdaq, our securities would not qualify as covered securities under the statute and we would
be subject to regulation in each state in which we offer our securities.

The nominal purchase price paid by our sponsor, sponsor affiliates and a consultant for the founder shares and the anti-dilution adjustment we intend to make with respect to the founder shares if the size of this offering is increased may result in significant dilution to the implied value of your public shares upon the consummation of our initial business combination, and the value of the founder shares following completion of our initial business combination is likely to be substantially higher than the nominal price paid for them, even if the trading price of our ordinary shares at such time is substantially less than $10.00 per share.

Because our sponsor, sponsor
affiliates and a consultant each acquired the founder shares at a nominal price (approximately $0.003 per share), our public shareholders
will incur an immediate and material dilution upon the closing of this offering. Additionally, our public shareholders may experience
further dilution if we increase the size of this offering pursuant to Rule 462(b) under the Securities Act and we effect with our sponsor
a share dividend or other appropriate mechanism, as applicable, with respect to our ordinary shares immediately prior to the consummation
of the offering in such amount as to maintain the ownership of founder shares by our initial shareholders at 20% of our issued and outstanding
ordinary shares upon the consummation of this offering.

While we are offering our ordinary
shares at an offering price of $10.00 per share and the amount in our trust account is initially anticipated to be $10.00 per public
share, implying an initial value of $10.00 per public share, our initial shareholders, prior to this offering, paid only a nominal aggregate
purchase price of $25,000 for 7,187,500 founder shares (including 937,500 founder shares subject to forfeiture by our sponsor and sponsor
affiliates if the over-allotment option is not exercised in full or in part by the underwriters), or approximately $0.003 per share.
As a result, the value of your public shares may be significantly diluted upon the consummation of our initial business combination,
when the founder shares are converted into public shares.

For example, the following
table shows the dilutive effect of the founder shares on the implied value of the public shares upon the consummation of our initial business